PT  - JOURNAL ARTICLE
AU  - Helwick, Caroline
ED  - Motzer, Robert J.
TI  - Trial Results Establish Clinical Benefit of RAD001 in Advanced Renal Cell Carcinoma
DP  - 2008 Aug 01
TA  - MD Conference Express
PG  - 11--11
VI  - 8
IP  - 4
4099  - http://mdc.sagepub.com/content/8/4/11.short
4100  - http://mdc.sagepub.com/content/8/4/11.full
AB  - Late-breaking results from a phase 3, randomized, double-blind, multicenter study provide convincing evidence that RAD001 is a safe and effective treatment for patients with metastatic renal cell carcinoma and validate mTOR inhibition as a cancer treatment.